Trial intelligence / Profile preview

Nebulized Nitroglycerin in PPHN

NCT05741229Completed

Sponsor
Alexandria University
Start
Jan 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of nitroglycerin in persistent pulmonary hypertension of the newborn (PPHN) (2 arms), sponsored by Alexandria University. Primary endpoints: Pulmonary Artery Pressure, Right Ventricular Function and 1 more. Started Jan 2024; status: completed.

02

Drugs

nitroglycerin
03

Conditions

persistent pulmonary hypertension of the newborn (PPHN)

Beyond the preview

Go deeper on NCT05741229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05741229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call